RIFAMPICIN-RESISTANT TUBERCULOSIS
Clinical trials for RIFAMPICIN-RESISTANT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new RIFAMPICIN-RESISTANT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for RIFAMPICIN-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 6-Month drug cocktail aims to tame resistant TB
Disease control Not yet recruitingThis phase 3 trial tests whether a 6-month combination of five drugs (bedaquiline, delamanid, delpazolid, levofloxacin, and pyrazinamide) works as well as standard treatment for rifampicin-resistant tuberculosis in adults and adolescents aged 15 and older in South Africa. The stu…
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: PHASE3 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope against Drug-Resistant TB: phase II trial launches
Disease control Not yet recruitingThis study tests whether adding acetohydroxamic acid (AHA) to a short-course antibiotic regimen can safely and effectively treat multidrug-resistant tuberculosis (MDR-TB). About 120 adults with confirmed MDR-TB will receive either AHA or a placebo alongside standard drugs. The go…
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New 9-Month pill regimen could tackle Drug-Resistant TB
Disease control Not yet recruitingThis phase 3 trial tests a 9-month, all-oral combination of four drugs (BLMZ) for people aged 12 and older with rifampicin-resistant tuberculosis. The goal is to see if this shorter regimen leads to a cure without the need for injections. Participants take the pills daily or week…
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a 6-Month pill combo beat Drug-Resistant TB?
Disease control Not yet recruitingThis study tests whether a 6-month combination of four drugs (bedaquiline, delamanid, linezolid, and levofloxacin) works as well as the standard longer treatment for drug-resistant tuberculosis. Fifty-two adults in Hubei, China will be randomly assigned to either the short or sta…
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: NA • Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Sputum DNA test aims to outsmart Drug-Resistant TB
Diagnosis Not yet recruitingThis trial tests a new DNA test that reads drug resistance directly from sputum samples in people with multidrug-resistant tuberculosis (MDR-TB). The goal is to see if this test helps doctors prescribe at least five effective drugs within 14 days of diagnosis, compared to current…
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: NA • Sponsor: University of Cape Town • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC